Jeffrey D Capello's Net Worth
$19 Million
Who is Jeffrey D Capello?
Jeffrey D Capello has an estimated net worth of $19 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., BOSTON SCIENTIFIC CORP, OvaScience, Inc., Flex Pharma, Inc., NEOGEN CORP, AGIOS PHARMACEUTICALS, INC., Sirtris Pharmaceuticals, Inc., and PERKINELMER INC.
SEC CIK
Jeffrey D Capello's CIK is 0001224108
Past Insider Trading and Trends
2013 was Jeffrey D Capello's most active year for acquiring shares with 24 total transactions. Jeffrey D Capello's most active month to acquire stocks was the month of January. 2013 was Jeffrey D Capello's most active year for disposing of shares, totalling 34 transactions. Jeffrey D Capello's most active month to dispose stocks was the month of January. 2013 saw Jeffrey D Capello paying a total of $6,914,257.14 for 1,360,914 shares, this is the most they've acquired in one year. In 2013 Jeffrey D Capello cashed out on 2,135,738 shares for a total of $12,827,479.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN INC. (BIIB) Snapshot price: $200.5
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +71.98% | 1.3K |
$331.76 | -$203,700.64 | 3.12K |
Feb 12
| |||
Form 4
| +97.71% | 896 |
$294.20 | -$119,445.20 | 1.81K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
∞
| 917 |
$304.69 | -$126,141.66 | 917 |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BOSTON SCIENTIFIC CORP (BSX) Snapshot price: $81.6
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.59% | -108.59K |
$11.70 | -$1,270,583.22 | 447 |
Nov 27
| |||
Form 4
| -26.05% | -38.41K |
$9.08 | -$709,568.98 | 109.04K |
Nov 26
| |||
Form 4
|
—
|
0
|
$9.83 | -$1,719,778.31 | 147.45K |
Nov 22 - Nov 25
| |||
Form 4
| -25.32% | -50.00K |
$9.05 | -$2,087,559.41 | 147.45K |
Aug 29
| |||
Form 4
| +4.42% | 8.36K |
$9.51 | -$59,979.57 | 197.45K |
Jun 16
| |||
Form 4
| +2.65% | 4.88K |
$8.45 | -$19,933.55 | 189.09K |
May 12
| |||
Form 4
| +3.98% | 7.06K |
$7.39 | -$25,236.85 | 184.21K |
Feb 28
| |||
Form 4
| +7.49% | 12.34K |
$7.33 | -$43,760.10 | 177.15K |
Feb 27
| |||
Form 4
| +4.74% | 7.46K |
$7.37 | -$26,620.44 | 164.81K |
Feb 23 - Feb 24
| |||
Form 4
| +9.45% | 13.59K |
$7.54 | -$50,201.32 | 157.35K |
Feb 16
| |||
Form 4
| +7.49% | 10.01K |
$5.95 | -$27,655.60 | 143.76K |
Jun 16
| |||
Form 4
| +3.84% | 4.94K |
$6.31 | -$14,475.14 | 133.75K |
May 12
| |||
Form 4
| +5.88% | 7.15K |
$6.36 | -$21,121.56 | 128.81K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +6.63% | 7.56K |
$6.00 | -$21,055.05 | 121.65K |
Feb 23 - Feb 24
| |||
Form 4
| +13.45% | 13.52K |
$5.97 | -$40,118.40 | 114.09K |
Feb 16
| |||
Form 4
| +11.05% | 10.01K |
$6.83 | -$31,800.48 | 100.56K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +2.32% | 2.06K |
$7.02 | -$6,718.14 | 90.56K |
Feb 24
| |||
Form 4
| +6.63% | 5.5K |
$7.04 | -$18,029.44 | 88.5K |
Feb 23
| |||
Form 4
| +19.77% | 13.7K |
$7.10 | -$46,441.10 | 83K |
Feb 16
| |||
Form 4
| +216.68% | 47.41K |
$6.10 | -$157,983.90 | 69.3K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +9.33% | 1.87K |
$7.80 | -$8,923.20 | 21.88K |
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
∞
| 20.01K |
$9.01 | -$83,892.11 | 20.01K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OvaScience, Inc. (TPST) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 11.11K |
$9.00 | $99,999.00 | 11.11K |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Flex Pharma, Inc. (SLRX) Snapshot price: $1.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEOGEN CORP (NEOG) Snapshot price: $15.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +42.89% | 1.78K |
$13.81 | $24,526.56 | 5.92K |
Oct 28
| |||
Form 4
| +62.21% | 6.08K |
$13.58 | $82,498.50 | 15.84K |
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||